These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9466648)

  • 1. p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias.
    Katabami M; Dosaka-Akita H; Honma K; Kimura K; Fujino M; Uchida Y; Mikami H; Ohsaki Y; Kawakami Y; Kikuchi K
    Int J Cancer; 1998 Feb; 75(4):504-11. PubMed ID: 9466648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer.
    Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
    Lung; 2001; 179(5):265-78. PubMed ID: 11976895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent cyclin D1 expression in chromate-induced lung cancers.
    Katabami M; Dosaka-Akita H; Mishina T; Honma K; Kimura K; Uchida Y; Morikawa K; Mikami H; Fukuda S; Inuyama Y; Ohsaki Y; Kawakami Y
    Hum Pathol; 2000 Aug; 31(8):973-9. PubMed ID: 10987259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumoconiosis-related lung cancers: preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis.
    Katabami M; Dosaka-Akita H; Honma K; Saitoh Y; Kimura K; Uchida Y; Mikami H; Ohsaki Y; Kawakami Y; Kikuchi K
    Am J Respir Crit Care Med; 2000 Jul; 162(1):295-300. PubMed ID: 10903257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.
    Nuorva K; Soini Y; Kamel D; Autio-Harmainen H; Risteli L; Risteli J; Vähäkangas K; Pääkkö P
    Am J Pathol; 1993 Mar; 142(3):725-32. PubMed ID: 8456936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein accumulates frequently in early bronchial neoplasia.
    Bennett WP; Colby TV; Travis WD; Borkowski A; Jones RT; Lane DP; Metcalf RA; Samet JM; Takeshima Y; Gu JR
    Cancer Res; 1993 Oct; 53(20):4817-22. PubMed ID: 8402667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium.
    Törmänen U; Nuorva K; Soini Y; Pääkkö P
    Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
    Hoshino H; Shibuya K; Chiyo M; Iyoda A; Yoshida S; Sekine Y; Iizasa T; Saitoh Y; Baba M; Hiroshima K; Ohwada H; Fujisawa T
    Lung Cancer; 2004 Nov; 46(2):187-96. PubMed ID: 15474667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas.
    Walker C; Robertson L; Myskow M; Dixon G
    Br J Cancer; 1995 Jul; 72(1):164-9. PubMed ID: 7599047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
    Hussein MR; Al-Badaiwy ZH; Guirguis MN
    J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
    Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
    Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer.
    Breuer RH; Snijders PJ; Sutedja TG; v d Linden H; Risse EK; Meijer CJ; Postmus PE; Smit EF
    Lung Cancer; 2003 May; 40(2):165-72. PubMed ID: 12711117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.
    Pankova OV; Denisov EV; Ponomaryova AA; Gerashchenko TS; Tuzikov SA; Perelmuter VM
    Tumour Biol; 2016 Mar; 37(3):3599-607. PubMed ID: 26456960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
    Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
    Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric examination of DNA ploidy, p53 and bcl-2 expression in primary squamous epithelial pulmonary carcinoma.
    Hołownia A; Kita J; Chyczewski L; Kozłowski M; Braszko JJ
    Rocz Akad Med Bialymst; 1999; 44():180-9. PubMed ID: 10697433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.